FIA
ABVX

FNY Investment Advisers’s Abivax ABVX Stock Holding History

FNY Investment Advisers’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Buy
7,605
+549
+8% +$62.1K 0.36% 76
2026
Q1 		$785K Buy
7,056
+4,466
+172% +$529K 0.34% 73
2025
Q4 		$349K Sell
2,590
-660
-20% -$72K 0.1% 171
2025
Q3 		$275K Buy
+3,250
New +$199K 0.09% 234

Other funds holding ABVX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
SCS
Syquant Capital SAS Paris, France $447M AUM 13.04% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.98B AUM 29.21% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

FNY Investment Advisers's ABVX Position: Q2 2026 in Review

FNY Investment Advisers increased its Abivax (ABVX) stake by 7.8% in Q2 2026, buying an estimated $62.1K and bringing the position to 7,605 shares worth $1.01M. The position accounts for 0.36% of the portfolio, ranked #76.

FNY Investment Advisers first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. 58 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • FNY Investment Advisers held 7,605 shares of Abivax worth $1.01M as of Q2 2026.
  • FNY Investment Advisers bought 549 Abivax shares in Q2 2026, an estimated $62.1K.
  • Abivax made up 0.36% of FNY Investment Advisers's portfolio in Q2 2026, its #76 holding.
  • FNY Investment Advisers first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • 58 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.